企業概要
Alignment Healthcare, Inc. is a prominent player in the United States healthcare sector, specifically operating within the Healthcare Plans industry by delivering a consumer-centric platform tailored for senior citizens. The company executes its strategy through Medicare Advantage plans, providing customized healthcare experiences designed to address the unique needs of the aging demographic. As of the latest data, the enterprise is valued with a market capitalization of $4.37B and generates annual revenue of $3.95B, supported by an operational workforce of 1,849 employees. These financial figures indicate a substantial market presence, positioning the firm as a significant entity capable of influencing the Medicare Advantage landscape despite its specific focus on senior care services.
財務健全性
The financial performance of Alignment Healthcare, Inc. is characterized by a revenue figure of $3.95B contrasted with a net income loss of $-724,000 over the trailing twelve months. This divergence between top-line revenue and bottom-line profitability reveals a cost structure where operating expenses, likely driven by customer acquisition and care delivery costs, currently outweigh the company's earnings before interest and taxes. However, the company maintains a robust EBITDA of $46.11M, suggesting that core operational cash generation remains positive despite the reported net loss. The firm demonstrates significant financial flexibility with free cash flow standing at $124.50M, a metric that allows for potential strategic investments or refinancing without immediate reliance on external equity. Liquidity is further supported by a cash balance of $604.23M, which substantially exceeds total debt obligations of $331.60M, indicating a conservative balance sheet approach regarding leverage. Nevertheless, the debt-to-equity ratio stands at 184.97, reflecting a highly leveraged capital structure relative to shareholders' equity. The current ratio of 1.71 suggests adequate short-term liquidity, as current assets are more than one and a half times current liabilities. Return on equity is recorded at -0.7%, signaling that shareholders have not yet seen a return on their capital, while return on assets sits at 1.1%, indicating efficient asset utilization relative to the total asset base. The gross margin is 12.4%, the operating margin is -1.1%, and the profit margin is -0.0%, collectively highlighting the challenges in translating revenue into net profit at this stage of the business model.
バリュエーション評価
Valuation metrics for Alignment Healthcare, Inc. present a mixed picture, with a forward P/E ratio of 30.33 utilized given the absence of a trailing P/E ratio due to negative earnings. The disparity between the missing trailing P/E and the forward P/E implies that the market is pricing in a significant expected turnaround in earnings trajectory over the coming fiscal year. The price-to-book ratio is elevated at 24.35, indicating that the market values the company at a substantial premium over its book value, likely anticipating high future growth or intangible asset appreciation. Alternative valuation multiples such as the price-to-sales ratio of 1.11 and the EV/EBITDA of 88.81 suggest that investors are willing to pay a high multiple relative to sales and earnings before interest, taxes, depreciation, and amortization. Regarding trading range, the stock has a 52-week high of $23.87 and a 52-week low of $11.62, meaning the current price sits at a specific point within this volatility band, reflecting recent market sentiment. The beta value of 1.20 indicates that the stock's price volatility is higher than the broader market, suggesting greater sensitivity to market swings compared to the S&P 500.
Growth & Income
Alignment Healthcare, Inc. exhibits robust expansion with a revenue growth year-over-year of 44.4%, while earnings growth is not applicable due to the current lack of profitability. This dynamic implies that the company is prioritizing top-line expansion and market share acquisition over immediate earnings accretion, a common strategy for capital-intensive healthcare ventures. As the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it reinvests all available earnings directly into business growth, operational scaling, and customer acquisition rather than distributing cash to shareholders. The overall growth and income profile is defined by aggressive revenue expansion funded by strong free cash flow, with income generation expected to materialize as the company scales its Medicare Advantage operations.